Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
measles, mumps, rubella and varicella vaccine live attenuated
- Development stage
- Preclinical
- Lead developer
- Shenzhen Kangtai Biological Products
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
This is a quadrivalent live attenuated combination vaccine developed by Shenzhen Kangtai Biological Products (BioKangtai). It is designed to simultaneously protect against four viral diseases: measles, mumps, rubella, and varicella (chickenpox). By combining these antigens into a single injection, the vaccine aims to simplify immunization schedules and improve compliance in pediatric populations. The vaccine works by introducing weakened forms of the viruses to stimulate a robust and long-lasting immune response, including the production of neutralizing antibodies and T-cell activation. As of current reports, this specific MMRV candidate is in the preclinical stage of development.
- Other names
- 麻腮风水痘联合减毒活疫苗MMRV vaccinemeasles, mumps, rubella and varicella combined live attenuated vaccine
Beyond the preview
Go deeper on measles, mumps, rubella and varicella vaccine live attenuated.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on measles, mumps, rubella and varicella vaccine live attenuated.